Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Sales | 734 | 444 | 492 | 554 | 716 |
| Cost of Goods | 261 | 300 | 268 | 308 | 358 |
| Gross Profit | 473 | 144 | 224 | 247 | 357 |
| Operating Expenses | 2,685 | 2,435 | 2,839 | 2,856 | 3,329 |
| Operating Income | -1,951 | -1,991 | -2,346 | -2,301 | -2,613 |
| Interest Expense | 0 | 0 | 0 | 0 | -1 |
| Other Income | 30 | 14 | 19 | 28 | 68 |
| Pre-tax Income | -1,921 | -1,977 | -2,328 | -2,273 | -2,544 |
| Net Income Continuous | -1,921 | -1,977 | -2,328 | -2,273 | -2,544 |
| Net Income | $-1,921 | $-1,977 | $-2,328 | $-2,273 | $-2,544 |
| EPS Basic Total Ops | -0.04 | -0.05 | -0.06 | -0.06 | -0.05 |
| EPS Basic Continuous Ops | -0.04 | -0.05 | -0.06 | -0.06 | -0.06 |
| EPS Diluted Total Ops | -0.04 | -0.05 | -0.06 | -0.06 | -0.05 |
| EPS Diluted Continuous Ops | -0.04 | -0.05 | -0.06 | -0.06 | -0.06 |
| EBITDA(a) | $-1,832 | $-1,869 | $-2,228 | $-2,147 | $-2,435 |